These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 28152258)

  • 21. Predicting Prostate Biopsy Outcomes: A Preliminary Investigation on Screening with Ultrahigh B-Value Diffusion-Weighted Imaging as an Innovative Diagnostic Biomarker.
    Zhang K; Shen Y; Zhang X; Ma L; Wang H; An N; Guo A; Ye H
    PLoS One; 2016; 11(3):e0151176. PubMed ID: 26963936
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimal high b-value for diffusion weighted MRI in diagnosing high risk prostate cancers in the peripheral zone.
    Agarwal HK; Mertan FV; Sankineni S; Bernardo M; Senegas J; Keupp J; Daar D; Merino M; Wood BJ; Pinto PA; Choyke PL; Turkbey B
    J Magn Reson Imaging; 2017 Jan; 45(1):125-131. PubMed ID: 27383502
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extracapsular extension in prostate cancer: added value of diffusion-weighted MRI in patients with equivocal findings on T2-weighted imaging.
    Woo S; Cho JY; Kim SY; Kim SH
    AJR Am J Roentgenol; 2015 Feb; 204(2):W168-75. PubMed ID: 25615777
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prostate cancer vs. post-biopsy hemorrhage: diagnosis with T2- and diffusion-weighted imaging.
    Rosenkrantz AB; Kopec M; Kong X; Melamed J; Dakwar G; Babb JS; Taouli B
    J Magn Reson Imaging; 2010 Jun; 31(6):1387-94. PubMed ID: 20512891
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effects of different computed high b-values on diffusion weighted imaging scores in Prostate Imaging Reporting and Data System version 2 of prostate cancer in peripheral zone].
    Wang W; Shao ZH; Zeng JQ; Wu DL; Wang GL; Wang PJ
    Zhonghua Yi Xue Za Zhi; 2017 Nov; 97(43):3401-3405. PubMed ID: 29179281
    [No Abstract]   [Full Text] [Related]  

  • 26. Relaxation along fictitious field, diffusion-weighted imaging, and T2 mapping of prostate cancer: Prediction of cancer aggressiveness.
    Jambor I; Pesola M; Merisaari H; Taimen P; Boström PJ; Liimatainen T; Aronen HJ
    Magn Reson Med; 2016 May; 75(5):2130-40. PubMed ID: 26094849
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Apparent diffusion coefficient for prostate cancer imaging: impact of B values.
    Peng Y; Jiang Y; Antic T; Sethi I; Schmid-Tannwald C; Eggener S; Oto A
    AJR Am J Roentgenol; 2014 Mar; 202(3):W247-53. PubMed ID: 24555621
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinically insignificant prostate cancer suitable for active surveillance according to Prostate Cancer Research International: Active surveillance criteria: Utility of PI-RADS v2.
    Yim JH; Kim CK; Kim JH
    J Magn Reson Imaging; 2018 Apr; 47(4):1072-1079. PubMed ID: 28901655
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer.
    Hambrock T; Somford DM; Huisman HJ; van Oort IM; Witjes JA; Hulsbergen-van de Kaa CA; Scheenen T; Barentsz JO
    Radiology; 2011 May; 259(2):453-61. PubMed ID: 21502392
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pilot Study of the Use of Hybrid Multidimensional T2-Weighted Imaging-DWI for the Diagnosis of Prostate Cancer and Evaluation of Gleason Score.
    Sadinski M; Karczmar G; Peng Y; Wang S; Jiang Y; Medved M; Yousuf A; Antic T; Oto A
    AJR Am J Roentgenol; 2016 Sep; 207(3):592-8. PubMed ID: 27352026
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative evaluation of the relative apparent diffusion coefficient values on multiparametric magnetic resonance imaging to predict higher Gleason score prostate cancer.
    Kato S; Kamijima S; Inaoka T; Kamiya N; Sasai D; Terada H; Hiruta N; Suzuki H
    Scand J Urol; 2018 Jun; 52(3):180-185. PubMed ID: 29939084
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diffusion-weighted MRI as a predictor of extracapsular extension in prostate cancer.
    Kim CK; Park SY; Park JJ; Park BK
    AJR Am J Roentgenol; 2014 Mar; 202(3):W270-6. PubMed ID: 24555624
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DWI of the prostate: Comparison of a faster diagonal acquisition to standard three-scan trace acquisition.
    Corcuera-Solano I; Wagner M; Hectors S; Lewis S; Titelbaum N; Stemmer A; Rastinehad A; Tewari A; Taouli B
    J Magn Reson Imaging; 2017 Dec; 46(6):1767-1775. PubMed ID: 28301097
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Performance of apparent diffusion coefficient values and ratios for the prediction of prostate cancer aggressiveness across different MRI acquisition settings.
    Karaarslan E; Altan Kus A; Alis D; Karaarslan UC; Saglican Y; Argun OB; Kural AR
    Diagn Interv Radiol; 2022 Jan; 28(1):12-20. PubMed ID: 35142611
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diffusion-weighted imaging in the assessment of prostate cancer: Comparison of zoomed imaging and conventional technique.
    Brendle C; Martirosian P; Schwenzer NF; Kaufmann S; Kruck S; Kramer U; Notohamiprodjo M; Nikolaou K; Schraml C
    Eur J Radiol; 2016 May; 85(5):893-900. PubMed ID: 27130048
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diffusion in prostate cancer detection on a 3T scanner: How many b-values are needed?
    de Perrot T; Scheffler M; Boto J; Delattre BM; Combescure C; Pusztaszeri M; Tille JC; Iselin C; Vallée JP
    J Magn Reson Imaging; 2016 Sep; 44(3):601-9. PubMed ID: 26914964
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical utility of apparent diffusion coefficient values obtained using high b-value when diagnosing prostate cancer using 3 tesla MRI: comparison between ultra-high b-value (2000 s/mm²) and standard high b-value (1000 s/mm²).
    Kitajima K; Takahashi S; Ueno Y; Yoshikawa T; Ohno Y; Obara M; Miyake H; Fujisawa M; Sugimura K
    J Magn Reson Imaging; 2012 Jul; 36(1):198-205. PubMed ID: 22371381
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Time-Dependent Diffusion in Prostate Cancer.
    Lemberskiy G; Rosenkrantz AB; Veraart J; Taneja SS; Novikov DS; Fieremans E
    Invest Radiol; 2017 Jul; 52(7):405-411. PubMed ID: 28187006
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of different mathematical models and different b-value ranges of diffusion-weighted imaging in peripheral zone prostate cancer detection using b-value up to 4500 s/mm2.
    Feng Z; Min X; Margolis DJ; Duan C; Chen Y; Sah VK; Chaudhary N; Li B; Ke Z; Zhang P; Wang L
    PLoS One; 2017; 12(2):e0172127. PubMed ID: 28199367
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prostate cancer: utility of diffusion-weighted imaging as a marker of side-specific risk of extracapsular extension.
    Rosenkrantz AB; Chandarana H; Gilet A; Deng FM; Babb JS; Melamed J; Taneja SS
    J Magn Reson Imaging; 2013 Aug; 38(2):312-9. PubMed ID: 23238968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.